NeuroDerm (NDRM) Priced

Developing a liquid formulation of levodopa for Parkinson's disease.

Health Care - Biotechnology

IPO Performance
Latest Trade $25.25 0.00 (0.0%)
First Day Return -8.5%
Return from IPO 152.5%
 
NeuroDerm IPO News more
  • .
IPO Data
IPO File Date 09/15/2014
Offer Price $10.00
Price Range $13.00 - $16.00
Offer Shares (mm) 4.5
Deal Size ($mm) 45
 
IPO Data
IPO Date 11/13/2014
Offer Price $10.00
Price Range $13.00 - $16.00
Offer Shares (mm) 4.5
Deal Size ($mm) $45
 
Underwriters
more
Business Overview
Developing a liquid formulation of levodopa for Parkinson's disease.
Developing a liquid formulation of levodopa for Parkinson's disease.
more
Company Data
Headquarters Rehovot, , Israel
Founded 2003
Employees 21
Website www.neuroderm.com
 

Performance vs. IPO Index (IPOUSA)